Tekla Capital Management LLC Axonics, Inc. Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$49.14 - $59.89 $3.97 Million - $4.84 Million	-80,760 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $2.59 Million - $3.16 Million	61,360 Added 316.29%	80,760 $4.03 Million
Q3 2020 Nov 13, 2020	SELL	$35.33 - $51.04 $307,371 - $444,048	-8,700 Reduced 30.96%	19,400 $990,000
Q4 2019 Feb 13, 2020	BUY	$19.57 - $28.96 $549,917 - $813,776	28,100 New	28,100 $779,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.